ROIX

Response Oncology, Inc. ROIX

Trading inactive

ROIX
Response Oncology, Inc. GNRS
The Greenrose Holding Company Inc. QMED
QMed, Inc. SYNI
Synvista Therapeutics, Inc. VTEQ
VeriTeQ Corporation LHRP
LifeHOUSE Holdings, LLC RFCS
Refocus Group, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ROIX GNRS QMED SYNI VTEQ LHRP RFCS
6M 0.00 % -85.71 % -99.00 % 0.00 % 0.00 % 0.00 % -99.99 %
YTD 0.00 % -85.71 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 %
1Y 0.00 % -99.97 % 0.00 % 0.00 % -100.00 % 0.00 % -99.99 %
3Y 0.00 % -100.00 % -99.00 % -99.00 % -100.00 % -99.00 % -100.00 %
5Y -90.00 % -100.00 % -99.00 % -99.67 % -100.00 % -99.00 % -100.00 %
10Y -99.00 % -100.00 % -99.96 % -99.00 % -100.00 % -99.00 % -100.00 %
From the beginning -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.00 % -100.00 %

Dividend